SCHEMBL2529295

SCHEMBL2529295

COC(=O)c1cc(F)cc2c1CC(C)(C)C(c1cccc(N3CCOCC3)c1)N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.40
FAAH O00519 1/20 0.38
NTRK1 P04629 1/20 0.37
NTRK3 Q16288 1/20 0.37
NTRK2 Q16620 1/20 0.37
BACE1 P56817 1/20 0.36
SETD2 Q9BYW2 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 4/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
ALOX15 P16050 3/20 0.35
GAA P10253 2/20 0.35
MAPK1 P28482 2/20 0.35
ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2533037 0.90 CYP2C19 (0.40) CYP2C19MRGPRX4CYP3A4MAPTMEN1
SCHEMBL2527845 0.90 CYP2C19 (0.43) CYP2C19FAAHNTRK1NTRK3NTRK2
SCHEMBL14331242 0.90 CYP2C19 (0.41) CYP2C19FAAHNTRK1NTRK3NTRK2
SCHEMBL2535082 0.87 CYP2C19 (0.38) CYP2C19FAAHNTRK1NTRK3NTRK2
SCHEMBL2530421 0.85 CYP2C19 (0.39) CYP2C19FAAHNTRK1NTRK3NTRK2
SCHEMBL15510211 0.84 CYP2C19 (0.42) CYP2C19FAAHNTRK1NTRK3NTRK2
SCHEMBL2531392 0.84 SETD2 (0.40) CYP2C19FAAHNTRK1NTRK3NTRK2
SCHEMBL2534812 0.84 SETD2 (0.40) CYP2C19FAAHNTRK1SETD2MRGPRX4
SCHEMBL2532540 0.82 TSHR (0.39) MAPTKMT2AALDH1A1LMNA
SCHEMBL2534808 0.81 CYP2C19 (0.40) CYP2C19MRGPRX4CYP3A4MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CYP2C19 273/4885FAAH 2146/4885NTRK1 3976/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 CYP2C19 273/4885FAAH 2146/4885NTRK1 3976/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.